Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Xanthine-based cell adhesion inhibitors particularly useful for periodontitis

March 24, 2000

Periostat receives U.K. marketing approval for treatment of chronic adult periodontitis

March 1, 2000

Periodontix raises funding for further development of HistaWash

Jan. 21, 2000

Atridox periodontal therapy approved in E.U.

Jan. 6, 2000

PAX9 gene mutation results in missing teeth

Jan. 5, 2000

Cathepsin C may be an important mediator in the development of periodontitis

Dec. 16, 1999

Positive phase III trial results for OraPharma's periodontal disease treatment

Dec. 1, 1999

Taiho prepares novel agents for periodontitis

Nov. 11, 1999

Atrix reports postmarketing study results for Atridox periodontitis therapy

Sep. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...